Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

CRVSCRVS
6 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in CORVUS PHARMACEUTICALS INC

Yes. Wellington Management Group holds 2,731,632 shares of CRVS (Corvus Pharmaceuticals), worth $40.8M, as of its Q2 2026 13F filing. It increased the position by 413,115 shares (+17.8%) from Q1 2026. Wellington Management Group has held CRVS since Q1 2025, across 6 quarterly 13F filings.

Current Value

$40.8M

Current Shares

2.7M

Total Value Change

+$40.5M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+17.8%
$40.8M0.0%$14.94
34
2026-Q1
Increased
2.3M
+636.8%
$33.9M0.0%$17.53
47
2025-Q4
Increased
314,683
+74.7%
$2.4M0.0%$7.49
39
2025-Q3
Increased
180,175
+76.0%
$1.3M0.0%$7.28
38
2025-Q2
Decreased
102,347
-2.4%
$409,3880.0%$3.89
0
2025-Q1
New
104,872
-
$333,4930.0%$3.38
33

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used